Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Polarityte Inc is a biotechnology business based in the US. Polarityte shares (PTE) are listed on the NASDAQ and all prices are listed in US Dollars. Polarityte employs 59 staff and has a trailing 12-month revenue of around $3 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $0.74 |
|---|---|
| 52-week range | $0.73 - $20.75 |
| 50-day moving average | $1.20 |
| 200-day moving average | $6.02 |
| Wall St. target price | $2.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-6.31 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.7434 from 2022-09-23
| 1 week (2022-09-16) | -17.63% |
|---|---|
| 1 month (2022-08-25) | -24.14% |
| 3 months (2022-06-24) | -55.49% |
| 6 months (2022-03-25) | 142.15% |
| 1 year (2021-09-24) | 4.51% |
|---|---|
| 2 years (2020-09-25) | -28.52% |
| 3 years (2019-09-25) | 4.01 |
| 5 years (2017-09-25) | 25.72 |
| Revenue TTM | $3 million |
|---|---|
| Gross profit TTM | $5.1 million |
| Return on assets TTM | -51.49% |
| Return on equity TTM | -57.37% |
| Profit margin | 0% |
| Book value | $4.12 |
| Market capitalisation | $4.2 million |
TTM: trailing 12 months
We're not expecting Polarityte to pay a dividend over the next 12 months.
Polarityte's shares were split on a 1:25 basis on 16 May 2022. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Polarityte shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Polarityte shares which in turn could have impacted Polarityte's share price.
Over the last 12 months, Polarityte's shares have ranged in value from as little as $0.7319 up to $20.75. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Polarityte's is 1.3108. This would suggest that Polarityte's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
PolarityTE, Inc. , a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company operates in two segments, Regenerative Medicine Products and Contract Services. It offers SkinTE, a tissue product used to repair, reconstruction, replacement, and supplementation of skin in patients for the treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts, as well as contract research services. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process; SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car; PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin; and other tissue regeneration products. PolarityTE, Inc. is headquartered in Salt Lake City, Utah.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Everything we know about the Lead Real Estate Co. IPO, plus information on how to buy in.
Everything we know about the Third Harmonic Bio IPO, plus information on how to buy in.
Everything we know about the LINKBANCORP IPO, plus information on how to buy in.
Here are the stocks that benefit from inflation, as well as industries to keep an eye on to reduce the impacts of inflation on your portfolio.